Date published: 2025-11-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

PKM2 Inhibitors

PKM2 inhibitors belong to a specific chemical class of compounds meticulously designed to modulate the activity of the PKM2 protein. PKM2, or pyruvate kinase M2 isoform, is a critical enzyme involved in glycolysis, a central metabolic pathway that generates energy and metabolic intermediates in cells. These inhibitors are thoughtfully crafted molecules engineered to interact with the PKM2 protein, influencing its normal function. Through these interactions, they might impact various cellular processes associated with energy metabolism, metabolic flux, and cellular responses, without directly altering its catalytic activity or its participation in glycolytic pathways. The design of PKM2 inhibitors is grounded in a comprehensive understanding of the structural and functional attributes of the PKM2 protein. Typically developed using advanced chemical synthesis methods and informed by insights from structural biology, these inhibitors are characterized by their ability to selectively bind to PKM2. This selectivity enables focused modulation of cellular pathways that rely on the activity of this specific enzyme. Unraveling the intricacies of cellular metabolism, energy production, and metabolic reprogramming often employ PKM2 inhibitors as valuable tools. The development and utilization of PKM2 inhibitors contribute to advancing our knowledge of the complex interplay between cellular components and metabolic dynamics, offering insights into the fundamental molecular mechanisms that govern energy production and contribute to cellular metabolism.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Shikonin

517-89-5sc-200391
sc-200391A
10 mg
50 mg
$75.00
$223.00
13
(1)

Shikonin, a natural compound from certain plants, has been studied as a potential inhibitor of PKM2. It may target PKM2 by interfering with its activity or regulation, affecting glycolysis in cancer cells. Shikonin's specific mechanism of action on PKM2 may involve modulation of its enzymatic activity or its role in metabolic pathways.

Oxalomalic acid sodium salt

89304-26-7sc-295985
sc-295985A
1 mg
5 mg
$51.00
$153.00
(0)

Oxalomalate inhibits PKM2 activity, likely by interacting with the enzyme and modulating its enzymatic function. This interference alters glycolytic pathways in cancer cells, potentially impacting their metabolic processes and growth.

Phosphoenolpyruvic acid, monopotassium salt

4265-07-0sc-208168
sc-208168A
sc-208168B
100 mg
250 mg
1 g
$76.00
$152.00
$296.00
1
(2)

PEP, an endogenous metabolite, can inhibit PKM2 by binding to the enzyme and regulating its activity. This regulation affects the glycolytic rate in cancer cells, providing insights into potential strategies for metabolic manipulation in cancer therapy.

Tyrphostin A23

118409-57-7sc-3554
10 mg
$110.00
13
(1)

Tyrphostin AG-1 has been studied for its effects on PKM2. Its mechanism of action involves inhibiting PKM2 activity and potentially influencing glycolytic pathways in cancer cells, presenting a potential avenue for targeting cancer metabolism.